Evidence map›Paper›PMID 27548652›Full record

ReviewCurrent opinion in rheumatology2016

Aberrant immune response with consequent vascular and connective tissue remodeling - causal to scleroderma and associated syndromes such as Raynaud phenomenon and other fibrosing syndromes?

Nedim Durmus, Sung-Hyun Park, Joan Reibman, Gabriele Grunig

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in rheumatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nedim DurmusaDepartment of Environmental Medicine bDepartment of Medicine, New York University Langone Medical Center, Tuxedo, New York, USA.
Sung-Hyun Park
Joan Reibman
Gabriele Grunig
NYU Langone Health · USNew York University · US

Funding

T helper 2 Inflammation & Severe Muscularization of Arteries in the Lungs.R01HL095764 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GRUNIG, GABRIELE · 2010 to 2014
$2.0M
Muscularization of pulmonary arteries induced by an adaptive immune responseR21HL092370 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GRUNIG, GABRIELE · 2009 to 2010
$413k
NHLBI NIH HHS R01 HL095764NHLBI NIH HHS R21 HL092370
6 · The paper itself

Abstract

purpose of reviewScleroderma and other autoimmune-induced connective tissue diseases are characterized by dysfunctions in the immune system, connective tissue and the vasculature. We are focusing on systemic sclerosis (SSc)-associated pulmonary hypertension, which remains a leading cause of death with only a 50-60% of 2-year survival rate. RECENT

findingsMuch research and translational efforts have been directed at understanding the immune response that causes SSc and the networked interactions with the connective tissue and the vasculature. One of the unexpected findings was that in some cases the pathogenic immune response in SSc resembles the immune response to helminth parasites. During coevolution, means of communication were developed which protect the host from over-colonization with parasites and which protect the parasite from excessive host responses. One explanation for the geographically clustered occurrence of SSc is that environmental exposures combined with genetic predisposition turn on triggers of molecular and cellular modules that were once initiated by parasites. SUMMARY: Future research is needed to further understand the parasite-derived signals that dampen the host response. Therapeutic helminth infection or treatment with parasite-derived response modifiers could be promising new management tools for autoimmune connective tissue diseases.

Indexed as

Connective TissueConnective Tissue DiseasesFibrosisGenetic Predisposition to DiseaseHumansHypertension, PulmonaryRaynaud DiseaseScleroderma, LocalizedScleroderma, SystemicSyndromeVascular Remodeling

Identifiers

PMID27548652
PMCPMC5114306
OpenAlexW2516310587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.